Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine dose versus volume in ultrasound-guided axillary brachial plexus block
NL-OMON26805Active, not recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mepivacaine in None (3 arms), sponsored by Sint Maartenskliniek. Primary endpoint: Duration of sensory axillary brachial plexus block. Started Oct 2012; status: active, not recruiting.
02
Drugs
mepivacaine
Beyond the preview
Go deeper on NL-OMON26805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26805.